If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
  Acta Obstetricia et Gynecologica ScandinavicaVolume 83 Issue 8, Pages 764 - 768 Published Online: 15 Jul 2004 Acta Obstet Gynecol Scand, 2005
Abstract | References | Full Text: HTML, PDF (Size: 66K) | Related Articles | Citation Tracking  Original Article Oral misoprostol vs. vaginal gemeprost prior to surgical termination of pregnancy in nulliparae Copyright Acta Obstet Gynecol Scand, 2004 KEYWORDS misoprostol • gemeprost • first-trimester termination of pregnancy ABSTRACTBackground. To compare the efficacy and side-effects of intravaginal gemeprost with those of oral misoprostol for cervical ripening prior to first-trimester pregnancy termination in nulliparous women. Methods. Retrospective analysis of surgical terminations of pregnancy performed before 90 days of gestation. Intravaginal gemeprost 1 mg or oral misoprostol 800 µg was administered 2 h before the procedure. Results. In total, 746 women were enrolled into the study, 84 received intravaginal gemeprost and 662 oral misoprostol. Median baseline cervical dilatation was significantly greater in women who received misoprostol before the operation than in those who received gemeprost (7 mm vs. 3 mm; p < 0.0001). The incidence of fever, vomiting and diarrhea was not different between the two groups. The incidence of abdominal pain with request for pain medication, emergency admission to operating room due to vaginal bleeding, hospital stay longer than 24 h and surgical repair of cervical injury due to Hegar dilatation was significantly higher among the gemeprost group than the misoprostol group. Conclusions. In cervical priming prior to first-trimester pregnancy termination in nulliparous women, oral misoprostol is more effective and is associated with fewer side-effects and complications than intravaginal gemeprost.
Submitted 28 July, 2003
|  |
